[1]兰 凯,张光伟,刘树义,等.骨化三醇对糖尿病肾病大鼠尿液Smad1水平的影响[J].医学信息,2021,34(01):75-77.[doi:10.3969/j.issn.1006-1959.2021.01.020]
 LAN Kai,ZHANG Guang-wei,LIU Shu-yi,et al.Effect of Calcitriol on Urine Smad1 Level in Rats with Diabetic Nephropathy[J].Medical Information,2021,34(01):75-77.[doi:10.3969/j.issn.1006-1959.2021.01.020]
点击复制

骨化三醇对糖尿病肾病大鼠尿液Smad1水平的影响()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年01期
页码:
75-77
栏目:
论著
出版日期:
2021-01-01

文章信息/Info

Title:
Effect of Calcitriol on Urine Smad1 Level in Rats with Diabetic Nephropathy
文章编号:
1006-1959(2021)01-0075-03
作者:
兰 凯张光伟刘树义
(西安医学院临床医学院,陕西 西安 710021)
Author(s):
LAN KaiZHANG Guang-weiLIU Shu-yiet al.
(Clinical School,Xi'an Medical University,Xi'an 710021,Shaanxi,China)
关键词:
糖尿病肾病骨化三醇Smad1
Keywords:
Diabetic nephropathyCalcitriolSmad1
分类号:
R692
DOI:
10.3969/j.issn.1006-1959.2021.01.020
文献标志码:
A
摘要:
目的 探讨骨化三醇对糖尿病肾病(DN)大鼠尿液中信号蛋白Smad1水平的影响及尿蛋白改变情况。方法 采用链尿佐菌素(STZ)腹腔注射的方法构建糖尿病肾病大鼠动物模型,将造模成功的大鼠随机分为骨化三醇组(T组)10只、DN组(D组)10只,并设置健康对照组(N组)10只。T组大鼠给予0.03 μg/(kg·d)的骨化三醇灌胃;D组与N组给予等量花生油灌胃。药物干预12周后检测各组大鼠尿液Smad1水平、24h尿蛋白定量及一般生化指标。结果 T组和D组Smad1水平和24h尿蛋白定量高于N组,差异有统计学意义(P<0.05);T组尿液Smad1水平和24h尿蛋白定量低于D组,差异有统计学意义(P<0.05)。尿液Smad1水平与24h尿蛋白量呈正相关(r=0.671,P<0.05)。结论 骨化三醇可能是通过调节信号蛋白Smad1水平,从而改善糖尿病肾病大鼠蛋白尿的产生。
Abstract:
Objective To investigate the effect of calcitriol on the level of signal protein Smad1 in the urine of diabetic nephropathy (DN) rats and the changes in urine protein.Methods The rat model of diabetic nephropathy was constructed by intraperitoneal injection of streptozotocin (STZ). The rats that were successfully modeled were randomly divided into calcitriol group (T group), 10 rats,DN group (D group) 10 animals, and a healthy control group (N group) 10 animals. The rats in group T were given 0.03 μg/(kg·d) calcitriol by gavage; group D and group N were given peanut oil by gavage. After 12 weeks of drug intervention, the levels of urine Smad1, 24h urine protein quantitative and general biochemical indicators of each group were detected.Results The levels of Smad1 and 24h urine protein in group T and D were higher than those in group N, the difference was statistically significant (P<0.05); the level of urine Smad1 and 24h urine protein in group T were lower than those in group D, the difference was statistically significant (P<0.05). The level of urine Smad1 was positively correlated with 24h urine protein (r=0.671,P<0.05).Conclusion Calcitriol may improve the production of proteinuria in rats with diabetic nephropathy by regulating the level of signal protein Smad1.

参考文献/References:

[1]付佳,徐琪,韩睿.维生素D及其受体在糖尿病肾病发病中的研究进展[J].中国医药导报,2020,17(7):23-26. [2]Li Q,Feng L,Li J,et al.Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy[J].Endocrine,2013,46(1):83-89. [3]李梦,田少江.Smad1蛋白在糖尿病肾病中的应用与研究进展[J].广东医学,2020,41(12):1294-1296. [4]Oshiro Y,Tanaka H,Kawasaki F,et al.Partial remission by cyclosporine monotherapy in a patient with membranous nephropathy superimposed diabetic nephropathy[J].CEN Case Reports,2016,5(2):219-222. [5]陈武,邹光美.检测血浆25-羟基维生素D水平在糖尿病肾病中的应用价值[J].检验医学与临床,2020,17(13):1850-1853. [6]张健,徐丹丹,王伟涛.胱抑素C、尿微量白蛋白/肌酐比值对早期糖尿病肾病的诊断价值[J].医学信息,2019,32(8):176-177. [7]Miraghajani MS,Esmaillzadeh A,Najafabadi MM,et al.Soy milk consumption, inflammation,coagulation, and oxidative stress among type 2 diabetic patients with nephropathy[J].Diabetes Care,2012,35(10):1981-1985. [8]Seyyed A,Bootorabi M,Ayremlou P,et al.The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial[J].Gynecol Endocrinol,2018,34(6):489-494. [9]Nam H,Kim HY,Choi JS,et al.Association between Serum 25-hydroxyvitamin D Levels and Type 2 Diabetes in Korean Adults[J].Chonnam Medical Journal,2017,53(1):73-77. [10]杨静,傅继华.糖尿病肾病病理机制及治疗措施的研究进展[J].医学研究与教育,2020,37(1):1-6. [11]Wang XM,Yao M,Liu SX,et a1.Interplay between the Notch and P13K/Akt pathways in high glucose induced podocyte apoptosis[J].Am J Physiol Renal Physiol,2014,30(6):205-213. [12]Meng X,Chung AK,Lan H.Role of the TGF-β/BMP-7/Smad pathways in renal diseases[J].Clinical Ence,2013,124(4):243-254. [13]Qu X,Li X,Zheng Y,et al.Regulation of Renal Fibrosis by Smad3 Thr388 Phosphorylation[J].Am J Pathol,2014,184(4):944-952. [14]Das R,Xu S,Quan X,et al.Upregulation of mitochondrial Nox4 mediates TGF -β- induced apoptosis in cultured mouse podocytes[J].Am J Physiol Renal Physiol,2014,306(2):F155. [15]刘俊芬,王琳琳,金玉杰,等.糖尿病肾病患者血清TGFβ/Smad蛋白、p38MAPK蛋白及尿α1-MG水平变化及意义[J].解放军预防医学杂志,2018,36(7):946-947,950. [16]Bi J,Watanabe H,Fujimura R,et al.A downstream molecule of 1,25-dihydroxyvitamin D3, alpha-1-acid glycoprotein, protects against mouse model of renal fibrosis[J].Scientific Reports, 2018,8(6):3590-3604. [17]蔡凯鹏,谢伟基.骨化三醇对早期糖尿病肾病患者相关炎性因子的影响[J].汕头大学医学院学报,2020,33(2):101-104. [18]李黎.血清1,25-二羟维生素D3超敏C反应蛋白与2型糖尿病肾病的相关性研究[J].中国药物与临床,2020,20(18):3039-3041. [19]陈武,邹光美.检测血浆25-羟基维生素D水平在糖尿病肾病中的应用价值[J].检验医学与临床,2020,17(13):1850-1853. [20]宁聪华,权莉,俞瑞,等.活性维生素D3下调核因子κB炎症通路对2型糖尿病大鼠肝脏保护作用的研究[J].中国糖尿病杂志,2020,28(8):613-618. [21]张爱鸣,厉钗微,高赛赛.C肽及其他因素与2型糖尿病肾病的相关性[J].浙江临床医学,2020,22(5):654-656.

相似文献/References:

[1]陈淑雯.肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察[J].医学信息,2018,31(05):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
 CHEN Shu-wen.Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu[J].Medical Information,2018,31(01):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
[2]何丽杰.中西医治疗糖尿病肾病的临床效果分析[J].医学信息,2018,31(10):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
 HE Li-jie.Clinical Effect Analysis of Diabetic Nephropathy Treated by Chinese and Western Medicine[J].Medical Information,2018,31(01):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
[3]贺 伟,高 峰.24 h尿微量白蛋白、血清胱抑素C水平与血清肌酐、尿素水平在2型糖尿病肾病早期诊断的意义[J].医学信息,2018,31(11):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
 HE Wei,GAO Feng.The Significance of 24 h Urinary Microalbumin,Serum Cystatin C and Serum Creatinine and Urea Levels in the Early Diagnosis of Type 2 Diabetic Nephropathy[J].Medical Information,2018,31(01):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
[4]黄秋菊.胱抑素C及脂蛋白α在早期糖尿病肾病诊断中的价值研究[J].医学信息,2018,31(14):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
 HUANG Qiu-ju.The Value of Cystatin C and Lipoprotein α in the Diagnosis of Early Diabetic Nephropathy[J].Medical Information,2018,31(01):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
[5]陆新虹,温玉洁,胡 欣,等.α-硫辛酸对2型糖尿病肾病患者 血清内脂素的影响研究[J].医学信息,2018,31(14):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
 LU Xin-hong,WEN Yu-jie,HU Xin,et al.Effect of α-lipoic Acid on Serum Visfatin in Patients with Type 2 Diabetic Nephropathy[J].Medical Information,2018,31(01):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
[6]郑小鹏,辛 华.糖尿病肾病研究进展[J].医学信息,2018,31(16):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
 ZHENG Xiao-peng,XIN Hua.Progress in the Study of Diabetic Nephropathy[J].Medical Information,2018,31(01):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
[7]李志俊,王 利,王 浩.姜黄素改善糖尿病肾病的作用机制研究[J].医学信息,2018,31(24):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
 LI Zhi-jun,WANG Li,WANG Hao.Study on the Mechanism of Curcumin in Improving Diabetic Nephropathy[J].Medical Information,2018,31(01):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
[8]肖学秀.益气活血汤联合西药治疗早期糖尿病肾病的临床观察[J].医学信息,2019,32(02):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
 XIAO Xue-xiu.Clinical Observation of Yiqi Huoxue Decoction Combined with Western Medicine in Treating Earlyn Diabetic Nephropathy[J].Medical Information,2019,32(01):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
[9]张国艳,张佳田,隋洪玉.糖尿病肾病大鼠动物模型建立及INF-α干预机制研究[J].医学信息,2019,32(05):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]
 ZHANG Guo-yan,ZHANG Jia-tian,SUI Hong-yu.Establishment of Animal Model of Diabetic Nephropathy Rats and Study of INF-α Intervention Mechanism[J].Medical Information,2019,32(01):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]
[10]吴怡琪,卢 文.皮肤AGEs荧光检测对糖尿病肾病的临床意义[J].医学信息,2019,32(06):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]
 WU Yi-qi,LU Wen.Clinical Significance of Skin AGEs Fluorescence Detection in Diabetic Kidney Disease[J].Medical Information,2019,32(01):101.[doi:10.3969/j.issn.1006-1959.2019.06.031]

更新日期/Last Update: 1900-01-01